Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6485)
All Articles published online
|
Publishing Process of This Article
|
Jun 28, 2016 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sheng WZ, Chen YS, Tu CT, He J, Zhang B, Gao WD. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer. World J Gastroenterol 2016; 22(24): 5532-5539 [PMID: 27350731 DOI: 10.3748/wjg.v22.i24.5532] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i24/5532.htm |
| Number | Citing Articles |
| 1 |
Wen-Jun Wang, Wei Yang, Zhi-Hua Ouyang, Jing-Bo Xue, Xue-Lin Li, Jian Zhang, Wen-Si He, Wen-Kang Chen, Yi-Guo Yan, Cheng Wang. MiR-21 promotes ECM degradation through inhibiting autophagy via the PTEN/akt/mTOR signaling pathway in human degenerated NP cells. Biomedicine & Pharmacotherapy 2018; 99: 725 doi: 10.1016/j.biopha.2018.01.154
|
| 2 |
Wanbo Liu, Sheng Chen, Bing Liu. Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study. Pediatric Surgery International 2016; 32(11): 1059 doi: 10.1007/s00383-016-3960-8
|
| 3 |
Nengyi Hou, Zhiyi Guo, Gaoping Zhao, Guiqing Jia, Bin Luo, Xiaogang Shen, Yifeng Bai. Inhibition of microRNA‐21‐3p suppresses proliferation as well as invasion and induces apoptosis by targeting RNA‐binding protein with multiple splicing through Smad4/extra cellular signal‐regulated protein kinase signalling pathway in human colorectal cancer HCT116 cells. Clinical and Experimental Pharmacology and Physiology 2018; 45(7): 729 doi: 10.1111/1440-1681.12931
|
| 4 |
Mariangela De Robertis, Maria Luana Poeta, Emanuela Signori, Vito Michele Fazio. Current understanding and clinical utility of miRNAs regulation of colon cancer stem cells. Seminars in Cancer Biology 2018; 53: 232 doi: 10.1016/j.semcancer.2018.08.008
|
| 5 |
Shanshan Wei, Wenwei Hu, Jun Feng, Yiting Geng. Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy. Cell Communication and Signaling 2022; 20(1) doi: 10.1186/s12964-022-00960-x
|
| 6 |
Bahareh Farasati Far, Kimia Vakili, Mobina Fathi, Shirin Yaghoobpoor, Mohammed Bhia, M. Reza Naimi- Jamal. The role of microRNA-21 (miR-21) in pathogenesis, diagnosis, and prognosis of gastrointestinal cancers: A review. Life Sciences 2023; 316: 121340 doi: 10.1016/j.lfs.2022.121340
|
| 7 |
Masoud Shirmohamadi, Elham Eghbali, Shiva Najjary, Ahad Mokhtarzadeh, Amir Baghbanzadeh Kojabad, Khalil Hajiasgharzadeh, Parisa Lotfinezhad, Behzad Baradaran. Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells. Journal of Cellular Physiology 2020; 235(2): 776 doi: 10.1002/jcp.29042
|
| 8 |
Z. Salehi, P. Haddad, Omid Tavallaei. Prediction of biomarker miRNAs signature in colorectal cancer metastasis to liver cancer. Electronic Journal of General Medicine 2018; 16(1): em100 doi: 10.29333/ejgm/93467
|
| 9 |
Amirhossein Bahreyni, Melika Rezaei, Afsane Bahrami, Majid Khazaei, Hamid Fiuji, Mikhail Ryzhikov, Gordon A. Ferns, Amir Avan, Seyed Mahdi Hassanian. Diagnostic, prognostic, and therapeutic potency of microRNA 21 in the pathogenesis of colon cancer, current status and prospective. Journal of Cellular Physiology 2019; 234(6): 8075 doi: 10.1002/jcp.27580
|
| 10 |
Ashlee M. Strubberg, Blair B. Madison. MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications. Disease Models & Mechanisms 2017; 10(3): 197 doi: 10.1242/dmm.027441
|
| 11 |
Mohadeseh Esmaeili, Maryam Keshani, Mehrdad Vakilian, Maryam Esmaeili, Maryam Peymani, Farzad Seyed Forootan, Tieu Lan Chau, Serkan Ismail Göktuna, Sayed Rasoul Zaker, Mohammad Hossein Nasr Esfahani, Kamran Ghaedi. Role of non-coding RNAs as novel biomarkers for detection of colorectal cancer progression through interaction with the cell signaling pathways. Gene 2020; 753: 144796 doi: 10.1016/j.gene.2020.144796
|
| 12 |
Ashutosh Singh, Ashutosh Kumar Singh, Rajanish Giri, Dhruv Kumar, Rohit Sharma, Martin Valis, Kamil Kuca, Neha Garg. The role of microRNA-21 in the onset and progression of cancer. Future Medicinal Chemistry 2021; 13(21): 1885 doi: 10.4155/fmc-2021-0096
|
| 13 |
Naghmeh Shirafkan, Behzad Mansoori, Ali Mohammadi, Navid Shomali, Mehri Ghasbi, Behzad Baradaran. MicroRNAs as novel biomarkers for colorectal cancer: New outlooks. Biomedicine & Pharmacotherapy 2018; 97: 1319 doi: 10.1016/j.biopha.2017.11.046
|
| 14 |
Keywan Mortezaee, Wrya Parwaie, Elahe Motevaseli, Hanifeh Mirtavoos-Mahyari, Ahmed Eleojo Musa, Dheyauldeen Shabeeb, Farid Esmaely, Masoud Najafi, Bagher Farhood. Targets for improving tumor response to radiotherapy. International Immunopharmacology 2019; 76: 105847 doi: 10.1016/j.intimp.2019.105847
|
| 15 |
Yu Yang, Jia-Xiang Guo, Zhi-Qiang Shao. miR-21 targets and inhibits tumor suppressor gene PTEN to promote prostate cancer cell proliferation and invasion: An experimental study. Asian Pacific Journal of Tropical Medicine 2017; 10(1): 87 doi: 10.1016/j.apjtm.2016.09.011
|
| 16 |
Liu Xiaoyu, Zhang Wei, Zhao Ming, Jia Guowei. Anti-apoptotic Effect of MiR-223-3p Suppressing PIK3C2A in Cardiomyocytes from Myocardial Infarction Rat Through Regulating PI3K/Akt Signaling Pathway. Cardiovascular Toxicology 2021; 21(8): 669 doi: 10.1007/s12012-021-09658-x
|
| 17 |
Chen Li, Kai Zhang, Jing Chen, Longbang Chen, Rui Wang, Xiaoyuan Chu. MicroRNAs as regulators and mediators of forkhead box transcription factors function in human cancers. Oncotarget 2017; 8(7): 12433 doi: 10.18632/oncotarget.14015
|